VERTEX PHARMACEUTICALS INC / MA (VRTX) › Shareholders' EquityVERTEX PHARMACEUTICALS INC / MA (VRTX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2010: $503.97M2011: $786.84M2012: $999.18M2013: $1.36B2014: $1.08B2015: $939.97M2016: $1.16B2017: $2.03B2018: $4.44B2019: $6.09B2020: $8.69B2021: $10.10B2022: $13.91B2023: $17.58B2024: $16.41B2025: $18.67B$18.67B2010Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$18.67B+13.7%2024$16.41B-6.7%2023$17.58B+26.4%2022$13.91B+37.7%2021$10.10B+16.3%2020$8.69B+42.8%2019$6.09B+37.2%2018$4.44B+118.6%2017$2.03B+75.4%2016$1.16B+23.0%2015$939.97M-12.6%2014$1.08B-20.7%2013$1.36B+35.8%2012$999.18M+27.0%2011$786.84M+56.1%2010$503.97M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share